What is HC Wainwright’s Estimate for Quantum-Si Q2 Earnings?

Quantum-Si Incorporated (NASDAQ:QSI) – Equities researchers at HC Wainwright reduced their Q2 2026 EPS estimates for Quantum-Si in a research report issued on Monday, May 11th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.13) per share for the quarter, down from their previous forecast of ($0.12). The consensus estimate for Quantum-Si’s current full-year earnings is ($0.50) per share. HC Wainwright also issued estimates for Quantum-Si’s Q4 2026 earnings at ($0.14) EPS, FY2026 earnings at ($0.49) EPS, FY2027 earnings at ($0.48) EPS and FY2028 earnings at ($0.37) EPS.

Quantum-Si (NASDAQ:QSI) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.02. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%.The company had revenue of $0.26 million for the quarter, compared to analysts’ expectations of $0.30 million.

QSI has been the topic of a number of other research reports. Canaccord Genuity Group dropped their price target on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, March 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a research report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $3.25.

Quantum-Si Stock Up 2.4%

QSI opened at $0.94 on Wednesday. The firm has a market cap of $204.36 million, a PE ratio of -1.85 and a beta of 3.15. The business has a fifty day simple moving average of $0.89 and a 200-day simple moving average of $1.17. Quantum-Si has a fifty-two week low of $0.69 and a fifty-two week high of $3.10.

Hedge Funds Weigh In On Quantum-Si

A number of hedge funds have recently added to or reduced their stakes in QSI. Prudential Financial Inc. acquired a new stake in Quantum-Si in the second quarter valued at approximately $25,000. Cerity Partners LLC acquired a new position in shares of Quantum-Si during the 2nd quarter worth $29,000. Capital Investment Advisory Services LLC increased its stake in shares of Quantum-Si by 100.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after purchasing an additional 10,000 shares during the last quarter. Curbstone Financial Management Corp bought a new position in shares of Quantum-Si during the 4th quarter valued at $26,000. Finally, Leonteq Securities AG acquired a new stake in shares of Quantum-Si in the 4th quarter valued at $28,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

Insider Activity at Quantum-Si

In other news, Director Paula Dowdy acquired 109,890 shares of the business’s stock in a transaction that occurred on Thursday, March 5th. The stock was acquired at an average cost of $0.95 per share, for a total transaction of $104,395.50. Following the completion of the acquisition, the director owned 269,107 shares in the company, valued at approximately $255,651.65. The trade was a 69.02% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jeffry R. Keyes sold 37,382 shares of Quantum-Si stock in a transaction on Monday, April 20th. The shares were sold at an average price of $1.01, for a total value of $37,755.82. Following the sale, the chief financial officer directly owned 1,769,963 shares of the company’s stock, valued at approximately $1,787,662.63. The trade was a 2.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 212,904 shares of company stock worth $205,021 in the last 90 days. 22.04% of the stock is owned by corporate insiders.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.